Attending the Alzheimer's Association®'s International Conference July 28 – Aug. 1? Stop by our poster presentations detailing how Aitia’s use of Causal AI and Digital Twins is advancing research on Alzheimer’s disease. #AI #DigitalTwins #Alzheimers #AAIC24
Aitia
Biotechnology Research
Somerville, Massachusetts 5,645 followers
Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
About us
Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of therapies for neurodegenerative diseases and Oncology. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. Aitia has translated those insights into its Gemini Digital Twins (computational representations of disease), which the company is using to discover new breakthrough therapies.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Somerville, Massachusetts
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Data Analytics, Bioinformatics, Genomics Data, Big Data, Causal AI, Drug Discovery, Virtual Patient, In silico trials, Clinical Trial, Virtual Patient, Drug Discovery, Target Discovery, multi-omic patient data, oncology, neurodegenerative disorders, Gemini Digital Twins, Digital Twins, Gemini, and Generative AI
Locations
-
Primary
Get directions
561 Windsor St
Somerville, Massachusetts 02143, US
Employees at Aitia
Updates
-
What is the current “state of the art" in AI-enabled life sciences technologies? Our CEO Colin Hill will be discussing the topic this week at the Sidley Austin LLP Bay Area Life Sciences Roundtable - an appropriate topic as today is #AIAppreciationDay! Register for the event here: https://bit.ly/4bHayMh #AI #Biotech #DrugDiscovery
-
-
Check out our latest feature in Nature's Biopharma Dealmakers on how Causal AI and Digital Twins are transforming drug discovery by uncovering hidden genetic and molecular mechanisms. At Aitia, we're using these technologies to accelerate breakthroughs in treating neurodegenerative disorders and cancer. This innovative approach has the potential to radically improve patient outcomes and speed up the drug development process. Read more here: https://lnkd.in/gpGvH8vr #DrugDiscovery #AI #Biotech
-
Join us today online for the GoldLab Symposium! Our CEO, Colin Hill, will discuss how Aitia is using causal AI, human multi-omic data, and Gemini Digital Twins to simulate billions of ‘experiments’ to discover novel drug targets and biomarkers. This process has uncovered hidden disease mechanisms and is allowing us to begin advancing a new treatment for Huntington’s disease. Don't miss Colin’s presentation! Watch the live stream starting at 11:55am ET: https://bit.ly/3V73DqU #GoldLabSymposium #Biotech #DrugDiscovery #AI
9:00-9:10am Larry Hunter Day 2 Welcome
goldlabfoundation.org
-
We're proud to support our very own Colin Hill as he sets out on this meaningful journey to raise funds for Life Science Cares Boston. Let's help him reach his goal for this noble cause! 🔗 Support his climb for a cause here ➡️ https://lnkd.in/gqJdRwqK #ATeam #LifeScienceCares
🏔️ Join Me in Making a Difference! This August, I'm embarking on a very special endeavor to provide greater opportunities to those less fortunate in our city. I’m joining a group of 20 other biotech pioneers, executives, and investors on a mission to alleviate poverty and create educational and employment opportunities to those in need by raising money for a groundbreaking foundation that supports the best performing non-profits in Boston, the Bay Area, San Diego, New York, and Philadelphia. The foundation is Life Science Cares Boston, started by close friend and biotech CEO and investor Rob Perez in 2016. The goal is to collectively raise $1M by each raising at least $50K. Please help me exceed this goal, and support my climb for a cause here ➡️ https://lnkd.in/e5yx28Ab And check out the special team of achievers assembled to make this ambitious goal a reality ➡️ https://lnkd.in/epGneRQj This trek is not just a challenge, but also a tribute to my father, Foster Lionel Hill, whose memory inspires this journey 🙏 It’s a deeply meaningful trek, representing our collective efforts to create lasting change. Thank you for your support! #TrekForACause #LifeScienceCares
timmerman-traverse-2024.justgiving-sites.com
-
We’re thrilled to announce our participation at the Convergence Forum on May 9-10, 2024. Colin Hill will be a featured panelist in an engaging session titled: “Where Will AI Make the Biggest Impact This Year..and in the Future? What Should Your Organization Be Doing?” alongside Anna Huyghues-Despointes, Chief Corporate Development and Strategy Officer at Owkin and Robert Plenge, EVP, Chief Research Officer at Bristol Myers Squibb. This session will explore the opportunities emerging from converging fields, tackle challenges in shifting markets, policies, and investing dynamics, and uncover potential game-changing scientific discoveries. More information about this event here ➡️ https://lnkd.in/eqtP66Au #CVFORUM24 #Aitia #ATeam #GeminiDigitalTwins #DigitalTwins #DrugDiscovery
-
-
In an insightful discussion, Aitia's CEO, Colin Hill, talks about the transformative potential of AI in biopharma R&D beyond traditional applications. Colin highlights how AI is crucial for uncovering complex genetic and molecular interactions in human diseases, leading to novel drug targets and more effective biomarkers. And also discusses challenges such as data acquisition, and the innovative use of #DigitalTwins PDX mice in partnership with Charles River Laboratories to enhance translatability between preclinical system and humans. Full article here ➡️ https://lnkd.in/gaYEDD4t #Aitia #ATeam #GeminiDigitalTwins #drugdiscovery The Conference Forum
Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets
theconferenceforum.org
-
Join us at this year’s at Align Summit MassBio, where the spotlight shines on AI and machine learning in drug discovery and development. Our CEO, Colin Hill, will discuss Aitia’s strategic initiatives and recent collaborations in the realm of AI-enabled drug discovery. Learn more about the event and our participation here: https://lnkd.in/ezhrkF8B #Aitia #ATeam #DigitalTwins #GeminiDigitalTwins #drugdiscovery
-
-
Last Thursday's Imagination in Action #MITforge2024 was a great convergence of the Boston AI community, uniting industry experts, visionary pioneers, emerging entrepreneurs, and distinguished academics. The event attracted a diverse mix of attendees from pre-seed investors to big tech leaders, making it one of the most vibrant technology gatherings of the month. Our CEO, Colin Hill contributed on two occasions. He first joined a panel alongside Geoffrey von Maltzahn, Ava Amini, Tanishq Abraham, PhD, and Zachary Ziegler to talk about the "AI Transformation of Life Sciences & Health". This discussion illuminated the profound impacts AI is having on healthcare and life sciences, sparking conversations on how these technologies are not only enhancing current practices but pioneering revolutionary approaches to health. Colin also presented a lightning talk on how #GeminiDigitalTwins are uncovering hidden biological mechanisms of disease. This pioneering work aims to pave the way for the next generation of breakthrough drugs, offering hope for diseases once deemed incurable. The presentation highlighted the impacts that AI is having in transforming the life sciences through deep insights and innovative approaches, showcasing the potential of AI to be a cornerstone in the cure for complex diseases such as cancer and Alzheimer’s. Thank you John Werner and Forbes for facilitating this remarkable gathering. #Aitia #ATeam #DigitalTwins #drugdiscovery
-
-
Delighted to share that Colin Hill will be taking the stage as a featured speaker at the upcoming Imagination in Action Summit at MIT #MITforge2024 diving into the world of #GeminiDigitalTwins and #CausalAI! Colin will also be moderating a panel on the transformative power of AI in Life Sciences and Healthcare. Get ready for a captivating discussion as our panelists shed light on the groundbreaking potential of AI in revolutionizing healthcare and life sciences. Join us for invaluable insights and visionary perspectives that are set to redefine the future. Don't miss out on this opportunity to be at the forefront of innovation! More on Imagination in Action: https://lnkd.in/gx3cb7Gx #Aitia #ATeam #DigitalTwins #drugdiscovery
-